{"id":"cec01503c5a8","type":"article","url":"https://hartvaat.nl/2025/06/13/griepvaccinatie-en-cardiovasculaire-bescherming-inflammatie-heroverwogen-bij-isc/","title":"Griepvaccinatie en cardiovasculaire bescherming: inflammatie heroverwogen bij ischemische hartziekte","title_en":"The flu shot and cardiovascular Protection: Rethinking inflammation in ischemic heart disease","category":"cholesterol","category_label":"Cholesterol","professions":["cardioloog","huisarts"],"tags":["acuut-hartfalen","bradycardie","covid-hart","inflammatie","slaapapneu"],"journal":"Atherosclerosis","doi":"https://www.atherosclerosis-journal.com/article/S0021-9150(25)01303-6/fulltext","source_url":"https://doi.org/https://www.atherosclerosis-journal.com/article/S0021-9150(25)01303-6/fulltext","authors":["Ole Fröbert","Ida B. Pedersen","Astrid J. Hjelholt","Christian Erikstrup","Sara Cajander"],"significance":5,"published":"2025-06-13","source_date":"2025-06-13","image":"","kennis":["https://hartvaat.nl/kennis/preventie/preventie-bij-diabetes/","https://hartvaat.nl/kennis/preventie/preventie-bij-ckd/"],"congress":"","summary_en":"This review examines the evidence supporting influenza vaccination as a cardiovascular preventive strategy. Observational studies and randomised trials consistently demonstrate reduced cardiovascular event rates among vaccinated individuals, with the greatest benefit seen after myocardial infarction.","created":"2026-07-03T10:25:44Z","updated":"2026-07-03T13:25:07Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Influenza-infectie is een bekende trigger van acute cardiovasculaire events via systemische inflammatie, endotheeldisfunctie en trombose. Dit overzicht bespreekt het bewijs voor griepvaccinatie als cardiovasculaire preventiestrategie.","abstract_original":"Influenza infection is a well-established trigger of acute cardiovascular events, particularly myocardial infarction, mediated by systemic inflammation, endothelial dysfunction, and thrombosis. In this review, we examine the evidence supporting influenza vaccination as a preventive strategy in cardiovascular disease. Observational studies and randomized trials consistently show reduced cardiovascular event rates among vaccinated individuals, with the most pronounced benefit seen after myocardial infarction."}